Orally Administered Lenalidomide (CC-5013) Is Anti-angiogenic In ...

Từ khóa » Cc-5013

• Efficacy Of CC-5013 (Revlimid Or Lenalidomide) In Patients With ...

• A Study Of CC-5013 Plus Dexamethasone Versus ... - Clinical Trials

• Definition Of CC-5013 - NCI Dictionary Of Cancer Terms

• Immunomodulatory Drug CC-5013 Overcomes Drug Resistance And ...

• Lenalidomide (CC-5013) | ≥99%(HPLC) | E3 Ligase Ligand Chemical

• EU Clinical Trials Register

• Phase III Intergroup Study Of Lenalidomide (CC-5013) Versus ...

• Lenalidomide (CC-5013) | Immunomodulator - MedChemExpress

• Lenalidomide: An Immunomodulatory Drug | Future Oncology

• Multiple-dose Pharmacokinetics And Safety Of CC-5013 In 15 ...

• Phase I Study To Determine The Safety, Tolerability And ... - Nature

• Clinical Trial On Multiple Myeloma: CC-5013, Lenalidomide - ICH GCP

• Preliminary Results Of A Phase II Study Of CC-5013 (Lenalidomide ...

• Lenalidomide (CC-5013) | CALIBRE SCIENTIFIC